Johnson & Johnson (NYSE: JNJ) reported its third quarter 2024 earnings outcomes as we speak.
Reported gross sales elevated 5.2% year-over-year to $22.5 billion.
GAAP earnings decreased 37.5% to $2.7 billion whereas EPS fell 34% to $1.11 in comparison with final 12 months. Adjusted EPS was down 9% to $2.42.
For full-year 2024, JNJ expects reported gross sales of $88.4-88.8 billion and adjusted EPS of $9.88-9.98.
(This story can be up to date shortly with an infographic)
Jakub Porzycki | Nurphoto | Getty PhotographsFirm: Couchbase Inc (BASE)Enterprise: Couchbase offers a cloud database platform for contemporary functions. Its...
President Donald Trump needs to revive the struggling coal business within the U.S. by deploying crops to energy the info...
Kate_sept2004 | E+ | Getty PhotographsLengthy-term care will be expensive, extending nicely past $100,000. But, monetary advisors say many households...
Utilized Supplies, Inc. (NASDAQ: AMAT) has reported blended outcomes for the second quarter, with earnings beating estimates and revenues barely...
U.S. Federal Reserve Chair Jerome Powell departs after holding a press convention following a two-day assembly of the Federal Open...
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.
